Study identifier:D961HC00004
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A randomised, single blind, three-way cross-over, single-centre study to assess the pharmacodynamics (intragastric pH) and pharmacokinetics after repeated oral administration of D961H 20 and 40 mg, and omeprazole 20 mg in Japanese healthy male subjects
gastrointestinal diseases
Phase 1
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|